Latest filing published 17 Mar 2021 for Fresh Tracks Therapeutics, Inc., €99k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Busard Brown: trading record in brief
Robert Busard Brown is a declared insider of Fresh Tracks Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 22 June 2020 and 15 March 2021, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €99k). The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2021: 1 purchase and no sales on the market.
On 17 March 2021 came the latest disclosure, an open-market purchase for €99k in Fresh Tracks Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert Busard Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$1.18100.0% of flowCommon StockSEC:0001062993-21-002782:0Canonical exit: 13 Jun 2021 (T+90)
- 86,957 sharesCommon StockSEC:0000911916-20-000134:0Canonical exit: 20 Sept 2020 (T+90)
2 of 2 declarations
